Been doing a little reading today, this is from the ASN Kidney week where DXB presented. Sure we know about our Poster already, I was more interested in Surrogate Endpoints with the FDA with all the current research being done around CKD trials, including Parasol with NephCure that DXB will contribute to (Mentioned in the last quarterly & our trial is actually pretty large in the FSGS space globally).
ASN Kidney Week was held in November 2023, so this is pretty current. I hope it’s useful. Just remember also that this isn’t just about FSGS.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)